What is Fenofibrate?
Category: Prescription Drugs
Most popular types: Tricor TriLipix Fenofibric Acid DR Show all
See also: Atorvastatin-fenofibrate Fibator
Fenofibrate is an antilipemic agent that is used as adjunct to dietary therapy for the treatment of adults with elevations of serum triglyceride levels (types IV and V hyperlipidemia) and adjunct to dietary therapy for the reduction of low density lipoprotein cholesterol.
| Purpose | Patients | Evaluations | Perceived Effectiveness |
|---|---|---|---|
| High triglycerides (hypertriglyceridemia) | 38 | 6 | |
| General health | 15 | 4 | |
| High cholesterol (hypercholesterolemia) | 14 | 6 | |
| Increased lipids in blood (hyperlipidemia) | 8 | 5 | |
| Support heart health | 7 | 1 |
- Major
- Moderate
- Slight
- None
- Can't tell
Side effects
Side effects as an overall problem
| Severity | Evaluations | Percentage |
|---|---|---|
| Severe | 10 | |
| Moderate | 5 | |
| Mild | 5 | |
| None | 68 |
Commonly reported side effects and conditions associated with Fenofibrate
| Side effect | Patients | Percentage |
|---|---|---|
| Flatulence | 2 | |
| Abdominal cramps | 1 | |
| Arthritis pain in shoulder joints | 1 | |
| Elevated creatine kinase (CK) level | 1 | |
| Headaches | 1 | |
| Increased serum creatinine | 1 |
Why patients stopped taking Fenofibrate
Multiple reasons could be selected
| Reason | Patients | Percentage |
|---|---|---|
| Doctor's advice | 17 | |
| Other | 14 | |
| Side effects too severe | 7 | |
| Change in health plan coverage | 6 | |
| Expense | 6 | |
| Did not seem to work | 5 | |
| Personal research | 4 | |
| Course of treatment ended | 3 |
Duration
Stopped taking Fenofibrate
| Duration | Patients | Percentage |
|---|---|---|
| Less than 1 month | 3 | |
| 1 - 6 months | 6 | |
| 6 months - 1 year | 6 | |
| 1 - 2 years | 13 | |
| 2 - 5 years | 13 | |
| 5 - 10 years | 5 | |
| 10 years or more | 5 |
What people switch to and from
Patients started taking Fenofibrate after stopping:
| Treatment | Patients | Percentage |
|---|---|---|
| Gemfibrozil (Lopid) | 5 | |
| Atorvastatin (Lipitor) | 2 | |
| Fenofibrate (Tricor) | 1 |
Patients stopped taking Fenofibrate and switched to:
| Treatment | Patients | Percentage |
|---|---|---|
| Gemfibrozil (Lopid) | 4 | |
| Pravastatin (Pravachol) | 2 | |
| Atorvastatin (Lipitor) | 1 | |
| Evolocumab (Repatha) | 1 | |
| Fenofibrate (Tricor) | 1 |
Last updated: